⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Semafor Unveils 450 Top Global CEOs and Government Leaders for Semafor World Economy 2026
prnewswire.com
HON
LLY
LAZ
QCOM
GS
BAH
BKR
PNC
ALL
MET
EXPE
JLL
MSFT
GOOG
NVDA
META
CRWD
VZ
BEN
CAVA
IBM
AMZN
INTC
AMD
CSCO
PANW
ETSY
UBER
LYFT
GE
USFD
SBUX
MCD
YUM
CVS
MRNA
PFE
JNJ
ABBV
BMY
GILD
REGN
AMGN
BIIB
VRTX
AZN
NVO
LULU
URBN
RL
MAT
UAA
INFY
ARM
ISRG
TDOC
TAP
FSLR
NEE
BE
PLUG
FCEL
RUN
SEDG
ENPH
ALNY
CRSP
EDIT
NTLA
ACLS
EXAS
ASO
ATHM
COIN
PYPL
MPWR
ON
AMAT
LRCX
KLAC
ASML
ADI
NXPI
TXN
WIT
HPE
OKTA
FTNT
DDOG
SNOW
PLTR
SPCE
RBLX
Inc. Names Re:Cognition Health Co-Founder and CEO Dr. Emer MacSweeney to Its 2026 Female Founders 500 List
prnewswire.com
LLY
Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer
businesswire.com
PFE
LLY
Alzheimer's Association Announces New Brain Health Roundtable
prnewswire.com
LLY
Nasal Mucosa Therapeutics Market Forecast 2026-2036: Market to Reach USD 31.7 Billion by 2036 at 18.3% CAGR
accessnewswire.com
GSK
JNJ
PFE
AZN
APT
NVS
LLY
Chainguard Launches Commercial Builds with Industry Leaders, Setting a New Standard for Verifiable, Zero-Vulnerability Software
prnewswire.com
ESTC
GLBZ
GRAF
TIGR
SNOW
FTNT
HPE
OPEN
CHKP
CAN
PANW
CRWD
ZS
DDOG
MDB
SMCI
AMD
NVDA
INTC
AMZN
GOOG
MSFT
IBM
ORCL
CRM
ADBE
PYPL
NFLX
CMCSA
DIS
VZ
T
KO
PEP
JNJ
PG
XOM
CVX
UNH
JPM
BAC
WFC
C
GS
MS
AMGN
GILD
BMY
PFE
MRK
ABBV
LLY
MDT
ISRG
COST
WMT
HD
MCD
SBUX
NKE
BA
CAT
GE
HON
RTX
LMT
GD
MMC
AXP
V
MA
MSCI
ADP
AMAT
ASML
QCOM
AVGO
TXN
ADSK
CDNS
SNPS
MRVL
GOOGL
Oral Small Molecule Amylin Receptor Agonist ASC39 Demonstrated Eloralintide-like Amylin Selectivity and Efficacy in Preclinical Models USA - English APAC - Traditional Chinese APAC - English
prnewswire.com
LLY
Digbi Health Capitalizes on GLP-1 Market Shift, Expands GLP Compass™, and Introduces Employer-Subsidized and Cash-Pay Pathways via Digbi RxFund™
globenewswire.com
LLY
Ulrich Wendt joins UK biotech Alchemab Therapeutics as Chief Business Officer to expand biopharma partnerships
businesswire.com
SNY
LLY
GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with Rising Demand for Metabolic Disease Therapies | MarkNtel Advisors
prnewswire.com
LLY
BIIB